News, views and contacts from the global Pharmaceutical industry
26 June 2017
Industry News

Deals this week: Kuros Biosciences, Suda, ProLynx
Swiss-based biotechnology company Kuros Biosciences intends to raise funds through the rights offering of shares of its common stock to raise between Sfr20.15m ($20.68m) and Sfr25m ($25.66m).

Seqirus develops cell-based influenza vaccine at Holly Springs facility in US
Seqirus, part of Australian biotechnology firm CSL, has successfully produced an industry-first cell-based influenza vaccine at its advanced manufacturing facility in Holly Springs, North Carolina, US.

Eli Lilly completes expansion of San Diego biotechnology centre in US
US-based pharmaceutical company Eli Lilly has completed the $90m expansion of its biotechnology centre in San Diego, California.

M&As this week: Pamplona Capital Management, Spherix, Quantum Hi-Tech China Biological
UK-based private equity company Pamplona Capital Management has agreed to acquire Parexel International Corporation by acquiring the entire outstanding shares of the company in an all-cash transaction.

Press Releases

Getting Up to Date with Complex Generics
Are you up-to-date on complex generics? You probably already know they are inherently difficult to duplicate, yet still reviewed by CDER-OGD (not CBER) using 505(j) Abbreviated New Drug Applications (ANDAs).

Freighter Capacity At Your Doorstep
Air Canada Cargo's dedicated freighter service provides year-round main and lower deck capacity for your shipments to key markets including Toronto, Atlanta, Dallas-Fort Worth, Mexico City, Bogota, Lima, and Frankfurt.

HOF Sonderanlagenbau's Control and Visualisation Systems Offer process-Oriented Operation
A rise in requirements for freeze-drying documentation and processes is consistently a challenge for system control.

Specialised Pharmaceutical Vibrating Separators
Russell Finex's customised vibrating separator The Finex Separatorâ„¢ has helped a pharmaceutical filler manufacturer of newly developed powder oxygen therapeutic (OC) increase productivity and product quality.

PBL Gains Approval to Advance Next Generation Anthrax Vaccine
Porton Biopharma Ltd (PBL) has announced that it has signed a modification to its contract with the US National Institute of Health's National Institute of Allergy and Infectious Diseases (NIAID) to advance a next generation intra-nasal anthrax vaccine. The contract modification is worth US$5.6 million.

White Papers

Sequential Sterilization of Simple Effluent Biowaste Streams
The AutoFlow SINK was designed for small laboratory applications such as research, virology, vaccines, and genetically modified organisms (GMO) in contract research organisations (CMO),...

Application Case Study: Parallel Process Development and Scale-Up by Factor 300
In this case study, three reactor systems (FlexyCUBE 70ml, FlexyPAT 2l, and ChemTeacktor 25l) are operated on the same PC using application software FlexySys....

Dehumidified Air Ensures Quality Hormone Packaging for Orion Pharmaceuticals
Production of hormone medication involves packing in foil blister packs. The process includes cooling and requires very cold machine...

Testing Parenteral Products for Micro Leaks, Container Closure Integrity Test
The E-Scan 655 tests container closure integrity in syringes, vials, and other liquid-filled parenteral...

Child Safe Packaging Today
As physicians become more reliant on prescribing medications to treat illness instead of advocating preventive measures, risks associated with accidental medication poisoning is...

Follow Us:   Facebook Facebook    Twitter Twitter   
Click here to unsubscribe from the newsletter | Privacy Policy
You are receiving this email because you are either a valued subscriber to Pharmaceutical Technology or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties. is a product of Kable. Copyright 2017 Kable, a trading division of Kable Intelligence Limited.